Form D Explorer

Inspect source fieldsReport a record issue

Form D — Protibea Therapeutics, Inc.

0001864104-25-000002 · filed Aug 18, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Other Health Care filings

Offering

Industry
Other Health Care
Exemptions
Rule 506(b)
Reported offering amount
$11,700,000
Reported amount sold
$200,000
Minimum investment
$100,000
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Protibea Therapeutics, Inc.
CIK
1864104
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2021
Address
1108 LEGACY CROSSING
GEORGETOWN, Texas 78628
Phone
915-490-0715

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗